WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects

From dramatic weight loss to dangerous side effects and fake Ozempic scams, here’s the truth about the GLP-1 craze gripping South Africa and Hollywood.

Raccontata dasciencealert.comindependent.co.ukiol.co.zagizmodo.comsciencedaily.com

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
iol.co.zaStai leggendo1 mesi fa

The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects

From dramatic weight loss to dangerous side effects and fake Ozempic scams, here’s the truth about the GLP-1 craze gripping South Africa and Hollywood.

originale
sciencealert.com1 mesi fa

Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds

Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the University of Liverpool in the UK, and…

Leggi questa versione → originale
sciencedaily.com1 mesi fa

People taking GLP-1 weight loss drugs like Ozempic started moving less

GLP-1 users (Ozempic, Wegovy) reduced activity despite weight loss: daily steps fell from 5,047 to 4,487, moderate-to-vigorous activity from 28 to 22 minutes. Since these drugs reduce muscle mass alongside fat, exercise intervention is essential—not optional—for protecting patient health outcomes.

Leggi questa versione → originale
gizmodo.com1 mesi fa

Can Ozempic Treat Alcoholism? Here's What You Should Know

A first Lancet RCT (26 weeks, n=100) found semaglutide reduced alcohol consumption and heavy drinking days vs placebo. The shared dopamine mechanism implies GLP-1s could address multiple addictions, reshaping Novo Nordisk's pipeline beyond obesity.

Leggi questa versione → originale
independent.co.uk1 mesi fa

Another effect of weight loss drugs could be changing the brain, research suggests

University of Colorado Anschutz found GLP-1 drugs boost brain connectivity within months, reducing addictive behaviors and improving attention. If confirmed, GLP-1s shift from metabolic to CNS drugs, reshaping pharma pipelines and enterprise health budgets.

Leggi questa versione → originale

Timeline cronologica

  1. giovedì 28 maggio 2026·sciencealert.com

    Weight Loss on GLP-1 Drugs Linked to Lower Risk of Disease, Study Finds

    Does losing weight by taking GLP-1 drugs such as Ozempic and Wegovy actually improve your risk of other diseases associated with obesity? New research led by scientists at the…

  2. giovedì 28 maggio 2026·independent.co.uk

    Another effect of weight loss drugs could be changing the brain, research suggests

    Scientists are looking to see how GLP-1 drugs may impact the brain and reshape people’s nervous systems

  3. venerdì 29 maggio 2026·iol.co.za

    Ozempic's shadow market: Inside South Africa's compounded weight-loss drug crisis

    Following a shocking investigation into South Africa's unregulated beauty economy, a new regulatory storm is brewing, targeting the dangerous market for compounded weight-loss…

  4. venerdì 29 maggio 2026·iol.co.za

    Inside South Africa's compounded weight-loss drug crisis

    Following a shocking investigation into South Africa's unregulated beauty economy, authorities are cracking down on the dangerous market for compounded weight-loss drugs like…

  5. venerdì 29 maggio 2026·gizmodo.com

    Can Ozempic Treat Alcoholism? Here's What You Should Know

    A recent trial is the latest to suggest that GLP-1s aren't just for treating diabetes and obesity.

  6. venerdì 29 maggio 2026·iol.co.za

    SAHPRA's enforcement action against weight-loss drugs like Ozempic and Mounjaro: What you need to know

    FOLLOWING an investigation into South Africa's aesthetics industry, the South African Health Products Regulatory Authority (SAHPRA), and South African Pharmacy Council (SAPC) have…

  7. domenica 31 maggio 2026·iol.co.za

    The good, bad and ugly of GLP-1 weight-loss drugs: Ozempic scams, celebrity hype and nasty side effects

    From dramatic weight loss to dangerous side effects and fake Ozempic scams, here’s the truth about the GLP-1 craze gripping South Africa and Hollywood.

  8. lunedì 1 giugno 2026·sciencedaily.com

    Ozempic changed obesity treatment, but experts say the real revolution is next

    The obesity treatment landscape is changing fast, with GLP-1 drugs opening the door to more effective care than ever before. Experts now envision a future where medications,…

  9. lunedì 1 giugno 2026·sciencedaily.com

    People taking GLP-1 weight loss drugs like Ozempic started moving less

    People taking popular weight-loss drugs such as Ozempic, Wegovy, Mounjaro, and Zepbound may be losing pounds, but they could also be moving less. Researchers analyzing Fitbit data…

  10. lunedì 1 giugno 2026·independent.co.uk

    The tortilla label change that weight-loss drug companies are cashing in on

    While a ‘GLP-1 friendly’ label may seem arbitrary, some medical experts say it may make people pay closer attention to what they’re eating